Literature DB >> 20119692

Nerve growth factor-beta expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma.

Lei-Bo Xu1, Chao Liu, Guo-Quan Gao, Xian-Huan Yu, Rui Zhang, Jie Wang.   

Abstract

BACKGROUND: Angiogenesis and lymphangiogenesis are important processes in the progression of malignant tumors. Previous studies have shown that nerve growth factor-beta (NGF-beta) can promote the initiation and progression of many tumors. In addition, vascular endothelial growth factor-C (VEGF-C) has become recognized as the most important lymphangiogenic factor. In the present study, the expression of NGF-beta in human hilar cholangiocarcinoma and its relationship with lymphangiogenesis, lymph node metastasis, nerve infiltration, and VEGF-C expression was investigated.
METHODS: Nerve growth factor-beta and VEGF-C expression were investigated by immunohistochemistry in samples from 28 cases of hilar cholangiocarcinoma. The lymphatic vessel density (LVD) in the tumor tissue that indicated lymphangiogenesis were calculated by immunostaining with the lymphendothelial-specific antibody D2-40. The relationship between NGF-beta expression and VEGF-C expression, lymphangiogenesis, lymph node metastasis, and nerve infiltration was evaluated.
RESULTS: The overexpression of NGF-beta and VEGF-C occurred in 57.1% (16/28) and 46.4% (13/28) of tumor samples, respectively. Nerve growth factor-beta overexpression was highly correlated with VEGF-C overexpression (P = 0.005), LVD (P < 0.001), lymph node metastasis (P = 0.021), nerve infiltration (P = 0.019), and tumor stage (P = 0.040). Furthermore, VEGF-C overexpression was highly correlated with LVD (P < 0.001) and lymph node metastasis (P < 0.001). However, there was no statistic significance in the relation between NGF-beta expression and sex (P = 0.185), age (P = 0.387), maximal tumor size (P = 0.736), Bismuth classification (P = 0.627) as well as histological grade (P = 0.203).
CONCLUSIONS: Nerve growth factor-beta might promote lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20119692     DOI: 10.1007/s00268-010-0417-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  38 in total

Review 1.  LYVE-1, the lymphatic system and tumor lymphangiogenesis.

Authors:  D G Jackson; R Prevo; S Clasper; S Banerji
Journal:  Trends Immunol       Date:  2001-06       Impact factor: 16.687

2.  Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors.

Authors:  M A Sortino; F Condorelli; C Vancheri; A Chiarenza; R Bernardini; U Consoli; P L Canonico
Journal:  Mol Endocrinol       Date:  2000-01

3.  Effect of topical application of nerve-growth factor on pressure ulcers.

Authors:  R Bernabei; F Landi; S Bonini; G Onder; A Lambiase; R Pola; L Aloe
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

4.  Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells.

Authors:  S K Raychaudhuri; S P Raychaudhuri; H Weltman; E M Farber
Journal:  Arch Dermatol Res       Date:  2001-06       Impact factor: 3.017

5.  Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components.

Authors:  Yoshihiko Tokusashi; Keiko Asai; Susumu Tamakawa; Masahiro Yamamoto; Masumi Yoshie; Yuji Yaginuma; Naoyuki Miyokawa; Takanori Aoki; Shuichi Kino; Shinichi Kasai; Katsuhiro Ogawa
Journal:  Int J Cancer       Date:  2005-03-10       Impact factor: 7.396

6.  Prognostic significance of vascular endothelial growth factor D in gastric carcinoma.

Authors:  Atsuo Shida; Shuichi Fujioka; Yoshio Ishibashi; Katsutoshi Kobayashi; Hiroshi Nimura; Norio Mitsumori; Yutaka Suzuki; Makio Kawakami; Mitsuyoshi Urashima; Katsuhiko Yanaga
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

Review 7.  Crosstalk between angiogenesis and lymphangiogenesis in tumor progression.

Authors:  C Scavelli; A Vacca; G Di Pietro; F Dammacco; D Ribatti
Journal:  Leukemia       Date:  2004-06       Impact factor: 11.528

8.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

Authors:  Shahid A Khan; Simon D Taylor-Robinson; Mireille B Toledano; Angus Beck; Paul Elliott; Howard C Thomas
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

Review 9.  Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors.

Authors:  N Weidner
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.

Authors:  Jen-Liang Su; Jin-Yuan Shih; Men-Luh Yen; Yung-Ming Jeng; Cheng-Chi Chang; Chang-Yao Hsieh; Lin-Hung Wei; Pan-Chyr Yang; Min-Liang Kuo
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

View more
  14 in total

Review 1.  Recent advances in the regulation of cholangiocarcinoma growth.

Authors:  Heather Francis; Gianfranco Alpini; Sharon DeMorrow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

2.  Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma.

Authors:  Xiao-Qing Yang; Yun-Fei Xu; Sen Guo; Yi Liu; Shang-Lei Ning; Xiao-Fei Lu; Hui Yang; Yu-Xin Chen
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

Review 3.  Autocrine regulation of biliary pathology by activated cholangiocytes.

Authors:  Kendal Jensen; Marco Marzioni; Kamruzzaman Munshi; Syeda Afroze; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

4.  Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.

Authors:  Dinorah Leyva-Illades; Matthew McMillin; Matthew Quinn; Sharon Demorrow
Journal:  Transl Gastrointest Cancer       Date:  2012

Review 5.  The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.

Authors:  Silvia Affo; Le-Xing Yu; Robert F Schwabe
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

6.  Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma.

Authors:  Kazuhide Urabe; Yoshiaki Murakami; Naru Kondo; Kenichiro Uemura; Yasushi Hashimoto; Naoya Nakagawa; Hayato Sasaki; Eiso Hiyama; Shinya Takahashi; Taijiro Sueda
Journal:  Dig Dis Sci       Date:  2015-11-07       Impact factor: 3.199

7.  Up-regulation of nerve growth factor in cholestatic livers and its hepatoprotective role against oxidative stress.

Authors:  Ming-Shian Tsai; Yu-Chun Lin; Cheuk-Kwan Sun; Shih-Che Huang; Po-Huang Lee; Ying-Hsien Kao
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

8.  Over-expression of nerve growth factor-β in human cholangiocarcinoma QBC939 cells promote tumor progression.

Authors:  Xiu-Jing Yue; Lei-Bo Xu; Man-Sheng Zhu; Rui Zhang; Chao Liu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

9.  Angiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma.

Authors:  Torsten Voigtländer; Sascha David; Kristina Thamm; Jerome Schlué; Jochen Metzger; Michael P Manns; Tim O Lankisch
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  Prostatic metastasis from intrahepatic cholangiocarcinoma.

Authors:  Georgi Tosev; Viktoria Schuetz; Joanne Nyarangi-Dix; Albrecht Stenzinger; Fabian Stoegbauer; Yakup Kulu; Jan P Radtke; Dogu Teber; Martin Hatzinger; Christoph Springfeld; Bruno C Koehler; Markus Hohenfellner
Journal:  Urol Case Rep       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.